Two AstraZeneca breast cancer drugs are better than one
12:05 EDT 2 Aug 2012 | SCRIP
Using a combination of AstraZeneca's aromatase inhibitor, anastrozole (Arimidex) with its oestrogen receptor modulator, Faslodex (fulvestrant) is more effective than either anastrozole alone or sequential anastrozole and fulvestrant in treating....
Original Article: Two AstraZeneca breast cancer drugs are better than one
More From BioPortfolio on "Two AstraZeneca breast cancer drugs are better than one"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
